Trial Profile
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 05 Mar 2013 Status changed from recruiting to completed.
- 05 Mar 2013 Primary endpoint 'Lesion-healing' has been met.
- 05 Mar 2013 Results presented at the 71st Annual Meeting of the American Academy of Dermatology.